The Health Information and Quality Authority has published a rapid health technology assessment (HTA) on the use of continuous glucose monitoring (CGM) systems in adults with type 1 diabetes.
Currently, not all adults with type 1 diabetes have access to CGM devices in Ireland. The HSE has a managed access programme for one of these systems; however, the arrangements for accessing the other systems has differed.
Annual HSE expenditure on CGMs for adults with type 1 increased from €0.9 million in 2016 to €30 million in 2022. Over 90% of the expenditure in 2022 related to the more expensive CGM systems as they have been more easily accessed by adults.
The budget impact of providing access to CGM to all adults with type 1 diabetes would be between €24.8 million and €84.8 million over five years, depending on which system is adopted, according to the report.